Illustration: Sarah Grillo/Axios
Dividend recaps, add-ons and continuation vehicles continue to characterize private equity dealmaking in health care, DealMax attendees said.
Why it matters: As private equity's exit backlog grows, so does anxiety about returning capital to limited partners.